This hypomethylation is consistent with elevated CNR1 expression observed in MAM-induced animal models (Figure 6C; D'Addario et al., 2017), suggesting that CNR1 methylation levels could serve as a potential biomarker for schizophrenia. This evidence concerns the gene CNR1 and schizophrenia.